ADC Therapeutics SA (NYSE:ADCT)
| 28.15 Delayed Data As of 3:59pm ET |  -0.10 / -0.35%Today’s Change | 20.01 Today|||52-Week Range 46.20 | -12.06% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 28.25 |
| Today’s open | 28.84 |
| Day’s range | 27.83 - 29.26 |
| Volume | 209,645 |
| Average volume (3 months) | 274,443 |
| Market cap | $2.2B |
Data as of 3:59pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | -116.16% |
| Earnings growth (this year) | -24.27% |
| Earnings growth (next 5 years) | +9.22% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.61 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 18, 2021 |
| EPS forecast (this quarter) | -$0.89 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$246.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
